DE3565934D1 - Use of propiophenone compound - Google Patents

Use of propiophenone compound

Info

Publication number
DE3565934D1
DE3565934D1 DE8585305253T DE3565934T DE3565934D1 DE 3565934 D1 DE3565934 D1 DE 3565934D1 DE 8585305253 T DE8585305253 T DE 8585305253T DE 3565934 T DE3565934 T DE 3565934T DE 3565934 D1 DE3565934 D1 DE 3565934D1
Authority
DE
Germany
Prior art keywords
propiophenone compound
propiophenone
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8585305253T
Other languages
English (en)
Inventor
Warren Charles Stern
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/634,451 external-priority patent/US4507323A/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of DE3565934D1 publication Critical patent/DE3565934D1/de
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE8585305253T 1984-07-25 1985-07-24 Use of propiophenone compound Expired DE3565934D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/634,451 US4507323A (en) 1984-07-25 1984-07-25 Treatment of psychosexual dysfunctions
US71507885A 1985-03-22 1985-03-22

Publications (1)

Publication Number Publication Date
DE3565934D1 true DE3565934D1 (en) 1988-12-08

Family

ID=27092162

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585305253T Expired DE3565934D1 (en) 1984-07-25 1985-07-24 Use of propiophenone compound

Country Status (4)

Country Link
EP (1) EP0171227B1 (de)
AU (1) AU583833B2 (de)
DE (1) DE3565934D1 (de)
IE (1) IE58734B1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2569184A1 (fr) * 1984-08-20 1986-02-21 Lafon Labor Derives de 1-(aminophenyl) therapeutique et leur procede de preparation
US7098206B2 (en) 1998-01-21 2006-08-29 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6998400B2 (en) 1998-01-22 2006-02-14 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6110973A (en) 1998-01-29 2000-08-29 Sepracor Methods for treating obesity and weight gain using optically pure (-)-bupropion
CA2318921A1 (en) 1998-01-29 1999-08-05 John R. Mccullough Pharmacological uses of optically pure (+)-bupropion
GB2340037A (en) * 1998-07-30 2000-02-16 Glaxo Group Ltd Compositions comprising bupropion for the treatment of premature ejaculation
US6734213B2 (en) 1999-01-20 2004-05-11 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6855820B2 (en) 1999-01-20 2005-02-15 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6342496B1 (en) 1999-03-01 2002-01-29 Sepracor Inc. Bupropion metabolites and methods of use
US6337328B1 (en) 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4347257A (en) * 1979-10-09 1982-08-31 Burroughs Wellcome Co. Prolactin suppression in mammals
US4425363A (en) * 1981-05-14 1984-01-10 Burroughs Wellcome Co. Treatment of tardive dyskinesia in mammals
US4435449A (en) * 1981-05-14 1984-03-06 Burroughs Wellcome Co. Treatment of minimal brain dysfunction (MBD)
US4438138A (en) * 1982-12-06 1984-03-20 Burroughs Wellcome Co. Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone
KR850001149A (ko) * 1983-02-03 1985-03-16 마이클 피터 잭슨 2-3차-부틸아미노-3'-클로로프로피오페논 말레에이트의 제조방법

Also Published As

Publication number Publication date
IE58734B1 (en) 1993-11-03
EP0171227A1 (de) 1986-02-12
IE851848L (en) 1986-01-25
AU583833B2 (en) 1989-05-11
AU4531585A (en) 1986-01-30
EP0171227B1 (de) 1988-11-02

Similar Documents

Publication Publication Date Title
ZA855593B (en) Use of propiophenone compound
IL76754A (en) Preparation of 1-hydroxyvitamin d compounds
IL76753A (en) Preparation of 1alpha-hydroxyvitamin d compounds
GB8413800D0 (en) Manufacture of pistons
GB8522990D0 (en) Moulding of dimensions
EP0158441A3 (en) Liposome-forming composition
IL75533A0 (en) Preparation of heteroaryloxyacetamides
GB8416380D0 (en) Manufacture of pistons
PT81055A (en) New compounds
GB8509322D0 (en) Determination of microconstituent
EP0171232A3 (en) Area-bonding tape
GB2167739B (en) Preparation of materials
DE3565934D1 (en) Use of propiophenone compound
GB2161492B (en) The manufacture of inverse microlatices
DE3561012D1 (en) Preparation of tamoxifen
GB8507789D0 (en) Preparation of 2-amino-s-triazines
GB8530319D0 (en) Preparation of alcohols
IL75655A (en) Manufacture of silylmetallocene compounds
DE3566540D1 (en) Preparation of fluoropyridines
IL76249A (en) Preparation of fluoroformates
IL76223A0 (en) Preparation of 1-(2-oxyaminosulphonyl-phenylsulphonyl-3-heteroaryl-ureas
GB8408292D0 (en) Quinolizinone compound
IL76216A0 (en) Preparation of sulphonylisoureas and-thioureas
GB8520403D0 (en) Preparation of aminolactone
GB8422162D0 (en) Preparation of alkyfurans

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee